These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10787411)
1. Specific recognition of androgens by their nuclear receptor. A structure-function study. Poujol N; Wurtz JM; Tahiri B; Lumbroso S; Nicolas JC; Moras D; Sultan C J Biol Chem; 2000 Aug; 275(31):24022-31. PubMed ID: 10787411 [TBL] [Abstract][Full Text] [Related]
2. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay. Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690 [TBL] [Abstract][Full Text] [Related]
3. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors. Berrevoets CA; Veldscholte J; Mulder E J Steroid Biochem Mol Biol; 1993 Dec; 46(6):731-6. PubMed ID: 8274406 [TBL] [Abstract][Full Text] [Related]
4. The amino terminus of the human AR is target for corepressor action and antihormone agonism. Dotzlaw H; Moehren U; Mink S; Cato AC; Iñiguez Lluhí JA; Baniahmad A Mol Endocrinol; 2002 Apr; 16(4):661-73. PubMed ID: 11923464 [TBL] [Abstract][Full Text] [Related]
5. Co-activator and co-repressor interplay on the human androgen receptor. Papaioannou M; Reeb C; Asim M; Dotzlaw H; Baniahmad A Andrologia; 2005 Dec; 37(6):211-2. PubMed ID: 16336251 [No Abstract] [Full Text] [Related]
6. Mutation of the androgen receptor at amino acid 708 (Gly-->Ala) abolishes partial agonist activity of steroidal antiandrogens. Terouanne B; Nirdé P; Rabenoelina F; Bourguet W; Sultan C; Auzou G Mol Pharmacol; 2003 Apr; 63(4):791-8. PubMed ID: 12644579 [TBL] [Abstract][Full Text] [Related]
7. Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei. Karvonen U; Jänne OA; Palvimo JJ FEBS Lett; 2002 Jul; 523(1-3):43-7. PubMed ID: 12123801 [TBL] [Abstract][Full Text] [Related]
9. Stabilization of androgen receptor protein is induced by agonist, not by antagonists. Furutani T; Watanabe T; Tanimoto K; Hashimoto T; Koutoku H; Kudoh M; Shimizu Y; Kato S; Shikama H Biochem Biophys Res Commun; 2002 Jun; 294(4):779-84. PubMed ID: 12061774 [TBL] [Abstract][Full Text] [Related]
10. Ligand-specific dynamics of the androgen receptor at its response element in living cells. Klokk TI; Kurys P; Elbi C; Nagaich AK; Hendarwanto A; Slagsvold T; Chang CY; Hager GL; Saatcioglu F Mol Cell Biol; 2007 Mar; 27(5):1823-43. PubMed ID: 17189428 [TBL] [Abstract][Full Text] [Related]
11. Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells. Brooke GN; Gamble SC; Hough MA; Begum S; Dart DA; Odontiadis M; Powell SM; Fioretti FM; Bryan RA; Waxman J; Wait R; Bevan CL Mol Cell Proteomics; 2015 May; 14(5):1201-16. PubMed ID: 25693800 [TBL] [Abstract][Full Text] [Related]
12. Non-steroidal antiandrogens act as AF-1 agonists under conditions of high androgen-receptor expression. Fuse H; Korenaga S; Sakari M; Hiyama T; Ito T; Kimura K; Kato S Prostate; 2007 May; 67(6):630-7. PubMed ID: 17342748 [TBL] [Abstract][Full Text] [Related]
13. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility. Marcelli M; Stenoien DL; Szafran AT; Simeoni S; Agoulnik IU; Weigel NL; Moran T; Mikic I; Price JH; Mancini MA J Cell Biochem; 2006 Jul; 98(4):770-88. PubMed ID: 16440331 [TBL] [Abstract][Full Text] [Related]
14. Structural Dynamics of Agonist and Antagonist Binding to the Androgen Receptor. Azhagiya Singam ER; Tachachartvanich P; La Merrill MA; Smith MT; Durkin KA J Phys Chem B; 2019 Sep; 123(36):7657-7666. PubMed ID: 31431014 [TBL] [Abstract][Full Text] [Related]
15. Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities. Vivat V; Gofflo D; Garcia T; Wurtz JM; Bourguet W; Philibert D; Gronemeyer H J Mol Endocrinol; 1997 Apr; 18(2):147-60. PubMed ID: 9134501 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity. Wang LG; Liu XM; Kreis W; Budman DR Biochem Biophys Res Commun; 1999 May; 259(1):21-8. PubMed ID: 10334909 [TBL] [Abstract][Full Text] [Related]
17. Conformational dynamics of androgen receptors bound to agonists and antagonists. Gim HJ; Park J; Jung ME; Houk KN Sci Rep; 2021 Aug; 11(1):15887. PubMed ID: 34354111 [TBL] [Abstract][Full Text] [Related]
18. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Tyagi RK; Lavrovsky Y; Ahn SC; Song CS; Chatterjee B; Roy AK Mol Endocrinol; 2000 Aug; 14(8):1162-74. PubMed ID: 10935541 [TBL] [Abstract][Full Text] [Related]
19. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations. Lyng FM; Jones GR; Rommerts FF Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915 [TBL] [Abstract][Full Text] [Related]